Collegium Pharmaceutical Investor Relations Material
Latest events
Q2 2025
Collegium Pharmaceutical
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Collegium Pharmaceutical Inc
Access all reports
Collegium Pharmaceutical Inc. is a specialty pharmaceutical company that focuses on developing and commercializing medications for the treatment of pain and related conditions. The company emphasizes the use of innovative drug delivery technologies to create products designed to address medical needs while minimizing potential risks associated with treatment. The company is headquartered in Stoughton, Massachusetts, and its shares are listed on the NASDAQ.
Key slides for Collegium Pharmaceutical Inc
Q2 2025
Collegium Pharmaceutical Inc
Q2 2025
Collegium Pharmaceutical Inc
Latest articles
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
Ticker symbol
COLL
Country
🇺🇸 United States